Business Wire

Experience the Future of Smarter AI for All at Lenovo’s Tenth Annual Global Tech World Event

3.10.2024 15:40:00 CEST | Business Wire | Press release

Share

The flagship event showcases Lenovo’s comprehensive portfolio of AI solutions, services, and devices with featured sessions from global leaders at Lenovo, AMD, Intel, Microsoft, NVIDIA, and more

On October 15, 2024, Lenovo will host its annual global innovation event, Tech World, in Bellevue, Washington. This marks the 10th consecutive year of the event and reflects a decade of innovation and transformation from the company. This year’s event will explore how Lenovo is delivering on the promise of artificial intelligence (AI) with end-to-end solutions fueling its mission of Smarter AI for All. Technology featured will include ground-breaking AI for Good projects, hybrid AI to empower both individuals and enterprises, and proven ways to fast-track and deploy generative AI.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241003339216/en/

What's next for AI? Join us October 15, 2024 at #LenovoTechWorld to hear top industry leaders discuss the future of AI innovation for all. Learn more: https://lnv.gy/3ZxcPr5 (Graphic: Business Wire)

The company will also discuss its ongoing investment and collaboration with partners to deliver the most advanced and comprehensive AI-ready, AI-enabled, and AI-optimized AI devices, infrastructure, solutions, and services for customers. The industry’s top partners will all join Lenovo on stage to discuss what’s next and build on the key product launches and new services announced earlier this year, including:

  • With Intel, Lenovo was among the first to launch AI-enabled PCs with Intel Core Ultra processors in the beginning of this year.
  • With AMD, Lenovo brought AI laptops with 3rd Gen Ryzen AI processors to market across consumers, commercial, and SMB users.
  • With Qualcomm and Microsoft, Lenovo announced the first Copilot+ PCs powered by Snapdragon X Elite: the Lenovo Yoga Slim 7x and ThinkPad T14s Gen 6.
  • With NVIDIA, Lenovo launched new Hybrid AI solutions that deliver the powerful generative AI applications to every enterprise and cloud to bring transformation capabilities to every industry through new AI professional services and Lenovo’s Spatial Computing Appliance of digital twin technology.

Tech World will feature a keynote session by Lenovo Chairman and CEO Yuanqing Yang, who will discuss Lenovo’s latest innovations and strategies in pursuit of “Smarter AI for All.” He will showcase the technologies making hybrid AI a reality for everyone, everywhere—at home, at work, and on the move.

Attendees can tune in in-person and virtually to experience how Lenovo uses hybrid AI to support large and small organizations. The latest technologies accelerate AI outcomes, scale and evolve private AI, and gain affordable and scalable access to metered GPU resources.

Additional Speakers include Lenovo’s newly appointed Chief Technology Officer, Dr. Tolga Kurtoglu, Lenovo’s President of the Emerging Technology Group, Dr. Yong Rui, alongside partner speakers like Lisa Su, Chair and CEO, AMD; Pat Gelsinger, CEO, Intel; Satya Nadella, Chairman and CEO, Microsoft; Mark Zuckerberg, Founder and CEO, Meta; and Jensen Huang, Founder and CEO, NVIDIA .

Through virtual content that can be explored anytime, Tech World ‘24 will be live-streamed across multiple time zones and hosted on-demand following the main broadcast. To register and see a full agenda of speakers, please visit Lenovo Tech World ’24.

Watch a decade of highlights from previous Tech World events:

About Lenovo

Lenovo is a US$57 billion revenue global technology powerhouse, ranked #248 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver Smarter Technology for All, Lenovo has built on its success as the world’s largest PC company with a pocket-to cloud portfolio of AI-enabled, AI-ready, and AI-optimized devices (PCs, workstations, smartphones, tablets), infrastructure (server, storage, edge, high performance computing and software defined infrastructure), software, solutions, and services. Lenovo’s continued investment in world-changing innovation is building a more equitable, trustworthy, and smarter future for everyone, everywhere. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). To find out more visit https://www.lenovo.com, and read about the latest news via our StoryHub.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241003339216/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders8.7.2026 15:00:00 CEST | Press release

Trial reports correlations between ketone levels and cognitive and psychiatric symptoms in individuals with schizophrenia-spectrum and bipolar-1 disorders Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders. The study, which enrolled participants with schizophrenia-spectrum or bipolar-1 disorders, demonstrated rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month RCT open-label phase. Furthermore, those who continued with the optional four-month single-arm ketogenic diet extension saw meaningful gains across metabolic, psychiatric, and cognitive measures. This press release features multimedia. View the full release here: https://www.businesswire.co

Teamily AI Publicly Launches Human+AI Social Platform to Make Building and Growing a Company Easy for Every Team8.7.2026 15:00:00 CEST | Press release

Teamily AI (https://Teamily.ai), together with its Agentic AI Infra platform TensorOpera AI (https://TensorOpera.ai), today announced the public launch of its Human+AI social platform, a product stack that has already served more than 5 million users around the world. Starting today in Palo Alto and rolling out simultaneously across dozens of countries, this first public launch opens the full stack to everyone with a single mission: to make building and growing a company easy for every person and every team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708584390/en/ "This is the moment we open our doors to the world," said co-founders Dr. Aiden Chaoyang He and Professor Salman Avestimehr. "We want every person and every team to be able to move from idea to product, from product to market, and from market to growth and investment, with an AI-native team by their side." At its core, Teamily AI enables humans and AI agents

Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform8.7.2026 14:30:00 CEST | Press release

Oversubscribed round follows the world-first compact upright proton treatment at Stanford Medicine — funding a single upright platform that will span imaging and treatment across multiple radiation modalities. Leo Cancer Care, the medical technology company working to reinvent how patients are imaged and treated by designing systems around the body’s natural upright position, today announced the close of an oversubscribed $65 million Series D financing. The round was led by Silicon Valley’s Yu Galaxy and welcomes new investors including Eventide Asset Management, alongside continued support from the company’s existing investors. Leading cancer institutions are already adopting the upright approach. Stanford Medicine delivered the world’s first compact upright proton therapy treatment on 4 June 2026. Dana-Farber Cancer Institute and McLaren Health Care are among the institutions bringing the upright platform into their programmes — adoption that spans world-leading academic centers and

LUMI AI Factory Selects IQM to Deploy Advanced Quantum Computer, Accelerating Hybrid HPC and AI Development8.7.2026 14:00:00 CEST | Press release

The Halocene H4 quantum computer, named LUMI-IQ, will be delivered and installed in 2027 The system will be hosted at CSC – IT Center for Science in Finland and integrated into the LUMI AI Factory The system will provide researchers, industry innovators, and developers across Europe with a unique, advanced experimental platform where quantum computing and artificial intelligence converge The LUMI AI Factory, led by CSC – IT Center for Science, has selected IQM Quantum Computers (Nasdaq: IQMX) to deliver IQM Halocene H4, an advanced quantum computer aimed at accelerating hybrid high-performance computing, artificial intelligence, and quantum computing capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708006791/en/ LUMI AI Factory selects IQM to deploy advanced quantum computer, accelerating hybrid HPC and AI development IQM Halocene H4 is the first and most advanced on-premises superconducting quantum computer o

Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations8.7.2026 14:00:00 CEST | Press release

Enpatoran could address a significant unmet need in lupus, specifically targeting cutaneous manifestations of the disease, which currently have no approved therapiesFDA's decision was supported by Phase 2 WILLOW study results, which demonstrated meaningful symptoms improvement, particularly among patients with active cutaneous manifestationsEnpatoran's potential to go beyond current treatment standards in lupus prompted FDA´s breakthrough designation, which is designed to expedite drug development and reviewNot intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to enpatoran for the treatment of lupus with active cutaneous manifestations. Enpatoran is an oral selective toll-like receptor (TLR) 7/8 inhibitor, designed to modulate pathways central to lupus-related inflammation. “For the 85% of lupus patients whose disease includes skin manif

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye